Pfizer's Hospira is recalling one lot each of the injectable hospital anesthetics bupivacaine hydrochloride (HCL) and lidocaine HCL after an investigation into a confirmed customer report revealed that a portion of each lot was mislabeled as the other product.
A notice posted on the FDA’s website states that the products were shipped out across the U.S., Puerto Rico and Guam between December 29, 2020 and April 15, 2021.
Click here to read the entire article.